Dysbiotic bacteria translocate in progressive SIV infection

Autor: Klase, Z, Ortiz, A, Deleage, C, Mudd, J C, Quiñones, M, Schwartzman, E, Klatt, N R, Canary, L, Estes, J D, Brenchley, J M

Publikováno v: In Mucosal Immunology September 2015 8(5):1009-1020

Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection

Autor: Klatt, N R, Estes, J D, Sun, X, Ortiz, A M, Barber, J S, Harris, L D, Cervasi, B, Yokomizo, L K, Pan, L, Vinton, C L, Tabb, B, Canary, L A, Dang, Q, Hirsch, V M, Alter, G, Belkaid, Y, Lifson, J D, Silvestri, G, Milner, J D, Paiardini, M, Haddad, E K, Brenchley, J M

Publikováno v: In Mucosal Immunology November 2012 5(6):646-657

A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection.

Autor: Scott J; Division of Allergy and Infectious DiseasesUniversity of WashingtonSeattleWAUSA., Fagalde M; Public Health - Seattle King CountySeattleWAUSA., Baer A; Public Health - Seattle King CountySeattleWAUSA., Glick S; Division of Allergy and Infectious DiseasesUniversity of WashingtonSeattleWAUSA.; Public Health - Seattle King CountySeattleWAUSA., Barash E; Public Health - Seattle King CountySeattleWAUSA., Armstrong H; Public Health - Seattle King CountySeattleWAUSA., Kowdley KV; Liver Institute NorthwestSeattleWAUSA., Golden MR; Division of Allergy and Infectious DiseasesUniversity of WashingtonSeattleWAUSA.; Public Health - Seattle King CountySeattleWAUSA., Millman AJ; Division of Viral HepatitisNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB PreventionCenters for Disease Control and PreventionAtlantaGAUSA., Nelson NP; Division of Viral HepatitisNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB PreventionCenters for Disease Control and PreventionAtlantaGAUSA., Canary L; Division of Viral HepatitisNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB PreventionCenters for Disease Control and PreventionAtlantaGAUSA., Messerschmidt M; HealthPoint Community Health CenterRentonWAUSA., Patel P; KaiserPermanenteSeattleWAUSA., Ninburg M; Hepatitis Education ProjectSeattleWAUSA., Duchin J; Division of Allergy and Infectious DiseasesUniversity of WashingtonSeattleWAUSA.; Public Health - Seattle King CountySeattleWAUSA.

Publikováno v: Hepatology communications [Hepatol Commun] 2020 Nov 07; Vol. 5 (3), pp. 387-399. Date of Electronic Publication: 2020 Nov 07 (Print Publication: 2021).

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities.

Autor: Estadt, Angela T.¹ (AUTHOR) estadt.24@osu.edu, Kline, David² (AUTHOR), Miller, William C.³ (AUTHOR), Feinberg, Judith⁴ (AUTHOR), Hurt, Christopher B.⁵ (AUTHOR), Mixson, L. Sarah⁶ (AUTHOR), Friedmann, Peter D.⁷ (AUTHOR), Lowe, Kelsa⁸ (AUTHOR), Tsui, Judith I.⁹ (AUTHOR), Young, April M.¹⁰ (AUTHOR), Cooper, Hannah¹¹ (AUTHOR), Korthuis, P. Todd¹² (AUTHOR), Pho, Mai T.¹³ (AUTHOR), Jenkins, Wiley¹⁴ (AUTHOR), Westergaard, Ryan P.⁸ (AUTHOR), Go, Vivian F.¹⁵ (AUTHOR), Brook, Daniel¹⁶ (AUTHOR), Smith, Gordon¹⁷ (AUTHOR), Rice, Dylan R.¹⁸ (AUTHOR), Lancaster, Kathryn E.¹⁹ (AUTHOR)

Publikováno v: Harm Reduction Journal. 11/29/2024, Vol. 21 Issue 1, p1-12. 12p.

Sharing the cure: Building primary care and public health infrastructure to improve the hepatitis C care continuum in Maryland.

Autor: Irvin R; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ntiri-Reid B; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Kleinman M; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Agee T; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hitt J; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Anaedozie O; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Arowolo T; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Cassidy-Stewart H; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Bush C; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Wilson LE; Infectious Disease Prevention and Health Services Bureau, Maryland Department of Health, Baltimore, MD, USA., Millman AJ; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA., Nelson NP; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA., Canary L; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA., Brinkley S; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Moon J; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sulkowski MS; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Thomas DL; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Melia MT; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publikováno v: Journal of viral hepatitis [J Viral Hepat] 2020 Dec; Vol. 27 (12), pp. 1388-1395. Date of Electronic Publication: 2020 Aug 05.